EFPIA - NEWSLETTER

EFPIA Newsletter 23 July 2020

News

23 July 2020 Free trade agreement with MRA in the best interest of European pharma, says new research

New research published today outlines the importance of a free trade agreement with a mutual recognition agreement for...

23 July 2020 EFPIA Statement on EU4Health Budget cuts

The devastating effects on people and societies of COVID-19 has underlined that investment in our health systems is...

Blogs

23 July 2020 Elephants, fairness, and magic formulas in drug pricing

About price, access and affordability

We published

Key Trade Data Points on the EU27 Pharmaceutical Supply Chain 09 July 2020 (Publications)

In 2019, 86.2% of EU27 imports of Human Medicinal Products came from Europe

2020: The Pharmaceutical Industry in Figures 30 June 2020 (Publications)

Our annual statistics leaflet

The root causes of unavailability and delay to innovative medicines 01 July 2020 (Publications)

Analysis developed with the support of Charles Rivers Associates (CRA)

What we are reading

Reviewing orphan drugs law: A tough equation 06 July 2020 (EurActiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶